Business Context and Reporting Period
This Form 8-K was filed by Genprex, Inc. on November 17, 2021. The filing serves as a current report to announce the availability of an investor presentation (Exhibit 99.1) intended for use in meetings with investors and analysts. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol GNPX. Genprex is classified as an emerging growth company.
Financial Metrics
The filing text does not provide specific financial data. This report is a procedural filing to disclose the existence of an investor presentation and does not contain revenue, profit, cash flow, margin, debt, or liquidity figures.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely addresses the dissemination of summary information via an investor presentation.
Guidance, Outlook, and Risks
- Investor Presentation: The company has furnished an investor presentation (Exhibit 99.1) which may be presented with modifications from time to time.
- Forward-Looking Statements: The company explicitly states it undertakes no duty or obligation to publicly update or revise the information contained in this report or the presentation, though it may do so at management's discretion.
- Legal Status of Information: The information in Item 8.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the content of the Investor Presentation (Exhibit 99.1) available on the company website (www.genprex.com) for specific operational or financial details.
- Confirm that the information in this 8-K is not incorporated by reference into other SEC filings.
- Note that the company has elected to use the extended transition period for complying with new or revised financial accounting standards as an emerging growth company.